Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Vertex Pharmaceuticals Inc
Recent news which mentions Vertex Pharmaceuticals Inc
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
October 30, 2024
Tags
Investing
Vertex Pharmaceuticals Inc
CME Group Inc
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Healthy Returns
Social issues
bluebird bio Inc
From
CNBC.com News
Cramer's Lightning Round: Builders FirstSource 'can go higher'
August 28, 2024
Tags
Market Outlook
Stock Picks
Investment strategy
From
CNBC.com News
Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'
April 08, 2024
Tags
Investing
Ford Motor Co
Vertex Pharmaceuticals Inc
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
Business
Pharmaceuticals
Health insurance
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
Biotech and Pharmaceuticals
CRISPR Therapeutics AG
Health care industry
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
US: News
Companies
Vertex Pharmaceuticals Inc
From
CNBC.com News
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023
Tags
Business
Health care industry
Science
From
CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
Tags
Health & Science
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
CNBC Investing Club: Newsletter
CNBC Investing Club: Analysis
Sanofi SA
From
CNBC.com News
20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean
October 09, 2023
Tags
Royal Caribbean Cruises Ltd
CNBC Investing Club: Analysis
DISH Network Corp
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
Biotech and Pharmaceuticals
Health & Science
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's Lightning Round: Vertex is 'excellent'
October 05, 2023
Tags
Business News
Topgolf Callaway Brands Corp
U/S/ Markets
From
CNBC.com News
Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more
May 01, 2023
Tags
Earnings
Diamondback Energy Inc
Markets
From
CNBC.com News
Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more
November 11, 2022
Tags
Netflix Inc
Finance
Beazer Homes USA Inc
From
CNBC.com News
Cramer's lightning round: Stay with Vertex Pharmaceuticals
October 27, 2022
Tags
Mad Money
S&P 500
Investment strategy
From
CNBC.com News
Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more
October 27, 2022
Tags
Capital One Financial Corp
Pinterest Inc
Vertex Pharmaceuticals Inc
From
CNBC.com News
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
July 05, 2022
Tags
Alphabet Class A
U/S/ Markets
Meta Platforms Inc
From
CNBC.com News
Cramer's lightning round: I'm sticking with Marvell Technology
June 22, 2022
Tags
Investment Strategy
Business
Marvell Technology Inc
From
CNBC.com News
Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more
May 02, 2022
Tags
Moody's Corp
Carmax Inc
Market Insider
From
CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
Tags
Okta Inc
Dow Inc
Mosaic Co
From
CNBC.com News
Stem cells may finally offer a cure for Type 1 diabetes
March 26, 2022
Tags
Technology
Science
Diabetes
From
CNBC.com News
Op-ed: Investors should look at technology, health care and industrials for long-term investing potential
March 23, 2022
Tickers
WAR
Tags
Mettler/Toledo International Inc
Thermo Fisher Scientific Inc
United Parcel Service Inc
From
CNBC.com News
The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing
March 12, 2022
Tags
Intellia Therapeutics Inc
Medicine
Genetics
From
CNBC.com News
Cramer's lightning round: Oppenheimer Holdings is cheap and should rally with the financials
January 04, 2022
Tags
APA Corp (US)
Investment strategy
U/S/ Markets
From
CNBC.com News
This 'hidden gem' and three other stocks look like buy-the-dip names after a volatile week on Wall Street, traders say
December 06, 2021
Tags
Microchip Technology Inc
Vertex Pharmaceuticals Inc
Investing
From
CNBC.com News
Stocks making the biggest moves midday: Vertex Pharmaceuticals, Moderna, Lennar, Salesforce and more
December 01, 2021
Tags
Stock markets
Breaking News: Markets
stocks
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.